Texas Cardiac Arrhythmia Institute, St. David's Medical Center, 3000 N. IH-35, Suite 720, Austin, TX 78705, USA; Department of Cardiovascular/Respiratory Diseases, Nephrology, Anesthesiology, and Geriatric Sciences, Policlinico Umberto I, Sapienza University of Rome, Rome, Italy.
Department of Cardiovascular/Respiratory Diseases, Nephrology, Anesthesiology, and Geriatric Sciences, Policlinico Umberto I, Sapienza University of Rome, Rome, Italy.
Card Electrophysiol Clin. 2022 Mar;14(1):1-9. doi: 10.1016/j.ccep.2021.10.001. Epub 2022 Jan 22.
COVID-19 mainly affects the respiratory system but has been correlated with cardiovascular manifestations such as myocarditis, heart failure, acute coronary syndromes, and arrhythmias. Cardiac arrhythmias are the second most frequent complication affecting about 30% of patients. Several mechanisms may lead to an increased risk of cardiac arrhythmias during COVID-19 infection, ranging from direct myocardial damage to extracardiac involvement. The aim of this review is to describe the role of COVID-19 in the pathogenesis of cardiac arrhythmias and provide a comprehensive guidance for their monitoring and management.
新型冠状病毒肺炎（COVID-19）主要影响呼吸系统，但与心血管表现相关，如心肌炎、心力衰竭、急性冠状动脉综合征和心律失常。心律失常是影响约 30%患者的第二大常见并发症。在 COVID-19 感染期间，多种机制可能导致心律失常风险增加，范围从直接心肌损伤到心脏外器官受累。本综述旨在描述 COVID-19 在心律失常发病机制中的作用，并为其监测和管理提供全面指导。
